Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takehiro Takahashi

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
Journal of Clinical Medicine|February 26, 2025
An Evaluation of Prognostic Factors in Cutaneous Squamous Cell Carcinoma: A Single-Center Study of 237 Japanese CasesEmi Yamazaki, Taku Fujimura, Manami Takahashi-Watanabe, et al.
The Journal of Dermatology|June 20, 2025
Long-Term Real-World Outcomes of Baricitinib in Severe Alopecia Areata: A 104-Week Retrospective Analysis From a Single InstituteMoyuka Wada-Irimada, Takehiro Takahashi, Mana Sekine, et al.
The Journal of Dermatology|January 27, 2025
Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single centerMoyuka Wada-Irimada, Takehiro Takahashi, Mana Sekine, et al.
Rheumatology (Oxford, England)|November 30, 2019
Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosisTakuya Miyagawa, Takashi Taniguchi, Ryosuke Saigusa, et al.
Experimental Dermatology|December 15, 2015
A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosisTakashi Yamashita, Yoshihide Asano, Takashi Taniguchi, et al.
European Journal of Dermatology : EJD|March 30, 2012
Clinical significance of serum decoy receptor 3 levels in patients with systemic sclerosisDaisuke Yamada, Yoshihide Asano, Takehiro Takahashi, et al.
Experimental Dermatology|November 26, 2014
A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosisRyosuke Saigusa, Yoshihide Asano, Takashi Taniguchi, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2013
Discovery of novel 7-membered cyclic amide derivatives that inhibit 11beta-hydroxysteroid dehydrogenase type 1Shuji Udagawa, Satoshi Sakami, Takahiro Takemura, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2015
Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosisRyosuke Saigusa, Yoshihide Asano, Takashi Taniguchi, et al.
The Journal of Investigative Dermatology|October 26, 2016
Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic SclerosisTakashi Yamashita, Yoshihide Asano, Takashi Taniguchi, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
Journal of Clinical Medicine|February 26, 2025
An Evaluation of Prognostic Factors in Cutaneous Squamous Cell Carcinoma: A Single-Center Study of 237 Japanese CasesEmi Yamazaki, Taku Fujimura, Manami Takahashi-Watanabe, et al.
The Journal of Dermatology|June 20, 2025
Long-Term Real-World Outcomes of Baricitinib in Severe Alopecia Areata: A 104-Week Retrospective Analysis From a Single InstituteMoyuka Wada-Irimada, Takehiro Takahashi, Mana Sekine, et al.
The Journal of Dermatology|January 27, 2025
Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single centerMoyuka Wada-Irimada, Takehiro Takahashi, Mana Sekine, et al.
Rheumatology (Oxford, England)|November 30, 2019
Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosisTakuya Miyagawa, Takashi Taniguchi, Ryosuke Saigusa, et al.
Experimental Dermatology|December 15, 2015
A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosisTakashi Yamashita, Yoshihide Asano, Takashi Taniguchi, et al.
European Journal of Dermatology : EJD|March 30, 2012
Clinical significance of serum decoy receptor 3 levels in patients with systemic sclerosisDaisuke Yamada, Yoshihide Asano, Takehiro Takahashi, et al.
Experimental Dermatology|November 26, 2014
A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosisRyosuke Saigusa, Yoshihide Asano, Takashi Taniguchi, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2013
Discovery of novel 7-membered cyclic amide derivatives that inhibit 11beta-hydroxysteroid dehydrogenase type 1Shuji Udagawa, Satoshi Sakami, Takahiro Takemura, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2015
Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosisRyosuke Saigusa, Yoshihide Asano, Takashi Taniguchi, et al.
The Journal of Investigative Dermatology|October 26, 2016
Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic SclerosisTakashi Yamashita, Yoshihide Asano, Takashi Taniguchi, et al.
Pageof 14